CN101129442A - 红景天沙棘片及其制备方法 - Google Patents
红景天沙棘片及其制备方法 Download PDFInfo
- Publication number
- CN101129442A CN101129442A CNA2007100500657A CN200710050065A CN101129442A CN 101129442 A CN101129442 A CN 101129442A CN A2007100500657 A CNA2007100500657 A CN A2007100500657A CN 200710050065 A CN200710050065 A CN 200710050065A CN 101129442 A CN101129442 A CN 101129442A
- Authority
- CN
- China
- Prior art keywords
- fine powder
- herba herminii
- ground
- hippophae
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 14
- 240000000950 Hippophae rhamnoides Species 0.000 title claims abstract description 13
- 244000042430 Rhodiola rosea Species 0.000 title claims description 11
- 235000003713 Rhodiola rosea Nutrition 0.000 title claims description 11
- 238000000034 method Methods 0.000 title abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 48
- 238000002156 mixing Methods 0.000 claims abstract description 46
- 241000229143 Hippophae Species 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 235000003935 Hippophae Nutrition 0.000 claims description 34
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 30
- 239000000706 filtrate Substances 0.000 claims description 30
- 239000008187 granular material Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000004375 Dextrin Substances 0.000 claims description 15
- 229920001353 Dextrin Polymers 0.000 claims description 15
- 230000001476 alcoholic effect Effects 0.000 claims description 15
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 15
- 235000019425 dextrin Nutrition 0.000 claims description 15
- 238000001035 drying Methods 0.000 abstract description 10
- 235000008434 ginseng Nutrition 0.000 abstract description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 241001165494 Rhodiola Species 0.000 abstract 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 241000208340 Araliaceae Species 0.000 abstract 2
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 13
- 230000036541 health Effects 0.000 description 12
- 210000004556 brain Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 206010013786 Dry skin Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 206010002660 Anoxia Diseases 0.000 description 3
- 241000976983 Anoxia Species 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 230000007953 anoxia Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- RUDVAOJNIYYYCQ-HUIKYQPJSA-N (1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosane-7,16-diol Chemical compound CC(C)=C[C@H]1C[C@](C)(O)[C@@H]2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@@]33CO[C@@]2(C3)O1 RUDVAOJNIYYYCQ-HUIKYQPJSA-N 0.000 description 1
- YGVHOSGNOYKRIH-UHFFFAOYSA-N 1,3,6-tri-O-galloyl-2,4-O-chebuloyl-beta-D-glucopyranose Natural products O1C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C2OC(=O)C=3C=C(O)C(O)=C(O)C=3)OC(=O)C(C3=4)=CC(O)=C(O)C=4OC(=O)C(O)C3C(CC(O)=O)C(=O)OC2C1COC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- YGVHOSGNOYKRIH-FJPMMHPYSA-N Chebulinic acid Chemical compound C([C@@H]1[C@H]2OC(=O)[C@@H](CC(O)=O)[C@@H]3[C@@H](C(OC=4C(O)=C(O)C=C(C3=4)C(=O)O[C@@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-FJPMMHPYSA-N 0.000 description 1
- MHDANAFDVQLLPY-UHFFFAOYSA-N Chebulinic acid Natural products OC(C1C(CC(=O)O)C(=O)OC2C(COC(=O)c3cc(O)c(O)c(O)c3)OC(OC(=O)c4cc(O)c(O)c(O)c4)C(OC(=O)c5cc(O)c(O)c(O)c15)C2OC(=O)c6cc(O)c(O)c(O)c6)C(=O)O MHDANAFDVQLLPY-UHFFFAOYSA-N 0.000 description 1
- 229920000585 Chebulinic acid Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- UGIVASYMZSZAMP-UHFFFAOYSA-N chebulagic acid Natural products OC1C2c3c(OC1=O)c(O)c(O)cc3C(=O)OC4C(OC(=O)c5cc(O)c(O)c(O)c5)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC4C6OC(=O)C2(O)C(=O)O UGIVASYMZSZAMP-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- RUDVAOJNIYYYCQ-UHFFFAOYSA-N jujubogenin Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)(O)CC(C=C(C)C)OC33OCC21C3 RUDVAOJNIYYYCQ-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NUPTUAXNMUIMFS-MIHIQLSESA-N terchebin Chemical compound C([C@@H]1[C@H]2OC(=O)C=3[C@H]4C5=C(C(O[C@@H]([C@H](OC(=O)C=6C=C(O)C(O)=C(O)C=6)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)C=C(C(=C5OC4(O)C(O)(O)C(=O)C=3)O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 NUPTUAXNMUIMFS-MIHIQLSESA-N 0.000 description 1
- ULYXEEKCDUUGNM-UHFFFAOYSA-N terchebin Natural products Oc1cc(cc(O)c1O)C(=O)OCC2OC(OC(=O)c3cc(O)c(O)c(O)c3)C4OC(=O)C5CC(=O)C(=O)C(=O)C5c6c(O)c(O)c(O)cc6C(=O)OC2C4OC(=O)c7cc(O)c(O)c(O)c7 ULYXEEKCDUUGNM-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100500657A CN100563697C (zh) | 2007-09-20 | 2007-09-20 | 红景天沙棘片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100500657A CN100563697C (zh) | 2007-09-20 | 2007-09-20 | 红景天沙棘片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101129442A true CN101129442A (zh) | 2008-02-27 |
CN100563697C CN100563697C (zh) | 2009-12-02 |
Family
ID=39126952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100500657A Expired - Fee Related CN100563697C (zh) | 2007-09-20 | 2007-09-20 | 红景天沙棘片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100563697C (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101347223B (zh) * | 2008-08-20 | 2010-12-15 | 朵海林 | 一种虫草马铃薯营养粉丝粉条 |
CN102329715A (zh) * | 2011-09-20 | 2012-01-25 | 成都圣弘源科贸有限公司 | 一种复方红景天酒及其制备方法 |
CN102406691A (zh) * | 2010-09-25 | 2012-04-11 | 王山 | 一种钙与酸性植物药组合制片的方法 |
CN102526457A (zh) * | 2012-01-18 | 2012-07-04 | 甘肃奇正实业集团有限公司 | 一种红景天组合物及其制备和应用 |
CN102578578A (zh) * | 2012-02-29 | 2012-07-18 | 范兆科 | 一种保健食品沙棘片的生产方法 |
CN103054034A (zh) * | 2013-02-04 | 2013-04-24 | 李玉兰 | 一种食品添加液及其制备方法 |
CN103627610A (zh) * | 2013-12-10 | 2014-03-12 | 尹治华 | 一种复方红景天酒及其制备方法 |
CN105918754A (zh) * | 2016-05-10 | 2016-09-07 | 雷正新 | 一种多功能固体饮料及其制备工艺 |
CN106619962A (zh) * | 2015-10-27 | 2017-05-10 | 北京尊道堂生物科技有限公司 | 一种细胞活力膏及其制作方法 |
CN108704008A (zh) * | 2018-08-20 | 2018-10-26 | 欧阳春彪 | 复方骆驼刺冲剂及其制备方法 |
CN111329906A (zh) * | 2020-04-03 | 2020-06-26 | 丛艳东 | 一种预防和治疗心脑血管疾病的中药 |
-
2007
- 2007-09-20 CN CNB2007100500657A patent/CN100563697C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101347223B (zh) * | 2008-08-20 | 2010-12-15 | 朵海林 | 一种虫草马铃薯营养粉丝粉条 |
CN102406691A (zh) * | 2010-09-25 | 2012-04-11 | 王山 | 一种钙与酸性植物药组合制片的方法 |
CN102329715A (zh) * | 2011-09-20 | 2012-01-25 | 成都圣弘源科贸有限公司 | 一种复方红景天酒及其制备方法 |
CN102526457A (zh) * | 2012-01-18 | 2012-07-04 | 甘肃奇正实业集团有限公司 | 一种红景天组合物及其制备和应用 |
CN102578578A (zh) * | 2012-02-29 | 2012-07-18 | 范兆科 | 一种保健食品沙棘片的生产方法 |
CN103054034A (zh) * | 2013-02-04 | 2013-04-24 | 李玉兰 | 一种食品添加液及其制备方法 |
CN103627610A (zh) * | 2013-12-10 | 2014-03-12 | 尹治华 | 一种复方红景天酒及其制备方法 |
CN106619962A (zh) * | 2015-10-27 | 2017-05-10 | 北京尊道堂生物科技有限公司 | 一种细胞活力膏及其制作方法 |
CN105918754A (zh) * | 2016-05-10 | 2016-09-07 | 雷正新 | 一种多功能固体饮料及其制备工艺 |
CN108704008A (zh) * | 2018-08-20 | 2018-10-26 | 欧阳春彪 | 复方骆驼刺冲剂及其制备方法 |
CN111329906A (zh) * | 2020-04-03 | 2020-06-26 | 丛艳东 | 一种预防和治疗心脑血管疾病的中药 |
Also Published As
Publication number | Publication date |
---|---|
CN100563697C (zh) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100563697C (zh) | 红景天沙棘片及其制备方法 | |
CN101791119B (zh) | 桦褐孔菌营养组合物 | |
CN100542584C (zh) | 复方沙棘含片及其制备方法 | |
CN1857475A (zh) | 预防及治疗心脑血管疾病的组合物及其应用 | |
CN105707598A (zh) | 一种解酒植物饮品及其制备方法 | |
CN103355619B (zh) | 一种滇橄榄葛根保健食品 | |
CN101129193B (zh) | 复方牦牛骨髓高钙片及其制备方法 | |
CN101129441B (zh) | 红景天胶囊及其制备方法 | |
CN106418525A (zh) | 一种发酵型桑叶咀嚼片及其制备方法 | |
CN104383259A (zh) | 一种苦瓜桑叶富铬胶囊及其制备方法 | |
CN102894364B (zh) | 一种苦瓜绿茶降糖含片的制备方法 | |
CN103142916B (zh) | 一种预防和治疗老年性痴呆病的药物 | |
CN102150856B (zh) | 含石斛粉料的混合物及其制备方法 | |
CN104997018A (zh) | 一种红豆杉酵素保健品及其制备方法和应用 | |
CN109010514A (zh) | 抗高原反应的组合物、保健品及制备方法 | |
CN101129192B (zh) | 虫草青稞糁子颗粒及其制备方法 | |
CN107320569A (zh) | 一种平脂咀嚼片及其制备方法 | |
CN105661496A (zh) | 一种高丽红参白芷细胞破壁超微粉的制备方法 | |
CN101164603A (zh) | 一种复方浓缩枸杞胶囊及其制备方法 | |
CN104940512A (zh) | 一种具有增强免疫力的中药组合物及其生产工艺 | |
CN103734420A (zh) | 一种刺梨石竹茶及其制作方法 | |
CN107125743A (zh) | 一种改善老年人心脑血管红树莓复合冲剂的配方 | |
CN102599312A (zh) | 低聚糖三七甜茶及其制备方法 | |
CN102614235A (zh) | 一种刺五加茶膏及其制备方法 | |
CN102132876B (zh) | 含杜仲粉料的混合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080227 Assignee: CHENGDU SHENGHONGYUAN BIOLOGICAL TECHNOLOGY CO., LTD. Assignor: Yin Zhihua Contract record no.: 2015510000032 Denomination of invention: Rhodiola rosea hippophae rhamnoides patch and method of preparing the same Granted publication date: 20091202 License type: Exclusive License Record date: 20150427 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160930 Address after: Wenjiang District 611130 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park Tsingtao Road No. 319 9-1-501, No. 9-2-501 Patentee after: CHENGDU SHENGHONGYUAN BIOLOGICAL TECHNOLOGY CO., LTD. Address before: 610041, No. 3, unit 4, building 6, 4 Siwei village, Wuhou District, Sichuan, Chengdu Patentee before: Yin Zhihua |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091202 Termination date: 20190920 |